(Q35671248)

9 August 2017

1 reference

title

The renin-angiotensin-aldosterone system in atrial fibrillation: a new therapeutic target? (English)

1 reference

9 August 2017

1 reference

Freestone B

1

1 reference

9 August 2017

Beevers DG

series ordinal

2

1 reference

9 August 2017

Lip GY

series ordinal

3

1 reference

9 August 2017

publication date

1 July 2004

1 reference

Journal of Human Hypertension

9 August 2017

published in

1 reference

9 August 2017

volume

18

1 reference

9 August 2017

issue

7

1 reference

9 August 2017

page(s)

461-465

1 reference

Guidelines for the diagnosis and treatment of chronic heart failure

9 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001694

Comparative effects of low and high doses of the angiotensin-converting enzyme inhibitor, lisinopril, on morbidity and mortality in chronic heart failure. ATLAS Study Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001694

Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001694

A clinical trial of the angiotensin-converting-enzyme inhibitor trandolapril in patients with left ventricular dysfunction after myocardial infarction. Trandolapril Cardiac Evaluation (TRACE) Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001694

beta Blockade after myocardial infarction: systematic review and meta regression analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001694

Angiotensin II AT(1) blockade normalizes cerebrovascular autoregulation and reduces cerebral ischemia in spontaneously hypertensive rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001694

Influence of drugs and gender on the arterial pulse wave and natriuretic peptide secretion in untreated patients with essential hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001694

Abnormal endothelium-dependent vascular relaxation in patients with essential hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001694

Correlation between left atrial size, prothrombotic state and markers of endothelial dysfunction in patients with lone chronic nonrheumatic atrial fibrillation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001694

Does atrial fibrillation confer a hypercoagulable state?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001694

The prothrombotic state in hypertension and the effects of antihypertensive treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001694

Angiotensin II regulates the expression of plasminogen activator inhibitor-1 in cultured endothelial cells. A potential link between the renin-angiotensin system and thrombosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001694

Use of irbesartan to maintain sinus rhythm in patients with long-lasting persistent atrial fibrillation: a prospective and randomized study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001694

Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001694

7 January 2021

Trandolapril reduces the incidence of atrial fibrillation after acute myocardial infarction in patients with left ventricular dysfunction

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001694

7 January 2021

Medical Research Council trial of treatment of hypertension in older adults: principal results. MRC Working Party

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001694

7 January 2021

Left atrial appendage thrombus is not uncommon in patients with acute atrial fibrillation and a recent embolic event: a transesophageal echocardiographic study

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001694

7 January 2021

Regulation of angiotensin II receptor subtypes during atrial fibrillation in humans

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001694

7 January 2021

Angiotensin II antagonist prevents electrical remodeling in atrial fibrillation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001694

7 January 2021

Stimulation of plasminogen activator inhibitor in vivo by infusion of angiotensin II. Evidence of a potential interaction between the renin-angiotensin system and fibrinolytic function

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001694

7 January 2021

Effects of acute angiotensin II type 1 receptor antagonism and angiotensin converting enzyme inhibition on plasma fibrinolytic parameters in patients with heart failure

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001694

7 January 2021

Effects of angiotensin converting enzyme and angiotensin II receptor inhibition on impaired fibrinolysis in systemic hypertension

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001694

7 January 2021

Effects of ramipril on plasma fibrinolytic balance in patients with acute anterior myocardial infarction. HEART Study Investigators

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001694

7 January 2021

Effect of enalapril on ventricular arrhythmias in congestive heart failure

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001694

7 January 2021

The role of atrial ectopics in initiating paroxysmal atrial fibrillation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001694

7 January 2021

Effects of lisinopril in patients with heart failure and chronic atrial fibrillation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001694

7 January 2021

Beta-adrenoceptor blockers in atrial fibrillation: the importance of partial agonist activity

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001694

7 January 2021

Identifiers

DOI

10.1038/SJ.JHH.1001694

1 reference

9 August 2017

1 reference